SPC181
Deoxýkólínsýru-natríumsalt
Status:
VeittApplication date:
24.1.2017Application published:
15.2.2017Grant published:
15.9.2022
Max expiry date:
7.2.2030Next due date:
28.2.2027Medicine name:
BelkyraMedicine for children:
No
Timeline
Today
24.1.2017Application
15.2.2017Publication
15.9.2022Registration
7.2.2027Expires
Marketing license
IS authorization number:
IS/1/16/071/01Date:
29.7.2016
Owner
Name:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterAddress:
1124 West Carson Street, Torrance US
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 12th Floor, Oakland, CA US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1758590
Annual fees
Number
Paid
Expires
Payer
Number: 1
Paid: 27.12.2024
Expires: 7.2.2026
Payer: Árnason Faktor ehf.
Number: 2
Paid: 12.1.2026
Expires: 7.2.2027
Payer: Árnason Faktor ehf.